Travere Therapeutics bobbled around today only ended up 0.37% since yesterday.
Currently TVTX isn't at a clear support/resistance line that seems tradable. But let's also consider momentum! Travere Therapeutics has had a nice run over the last year and provided good returns to shareholders. Over the previous year, the asset has grown 256.68 percent which isn't too bad. TVTX might find some support at the 30.88 level, buyers might push the price back up from here. But it's not very clear what will happen.